Design Therapeutics, Inc. (DSGN)
USD 5.95
(-4.8%)
USD 5.95
(-4.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -58.56 Million | -51.31 Million | -29.37 Million | -8.66 Million | -139 Thousand |
| Net Income | -66.86 Million | -63.3 Million | -35.53 Million | -8.28 Million | -2.04 Million |
| Depreciation & Amortization | 537 Thousand | 406 Thousand | 129 Thousand | 5000.00 | - |
| Deferred income taxes | - | - | -77 Thousand | -71 Thousand | - |
| Stock-based compensation | 13.08 Million | 10.92 Million | 4.68 Million | 450 Thousand | - |
| Change in working capital | 728 Thousand | 1.99 Million | 1.39 Million | -811 Thousand | 1.81 Million |
| Other non-cash items | 9.35 Million | -1.33 Million | 19 Thousand | 38 Thousand | 95 Thousand |
| Investing Cash Flow | 52.53 Million | -220.98 Million | -53.64 Million | -33.56 Million | - |
| Investments in PPE | -256 Thousand | -918 Thousand | -1.53 Million | -76 Thousand | - |
| Acquisitions | - | 39 Thousand | 52.1 Thousand | 33.48 Thousand | - |
| Investment purchases | -224.7 Million | -312.99 Million | -86.26 Million | -55.58 Million | - |
| Sales/Maturities of investments | 277.49 Million | 92.89 Million | 34.15 Million | 22.1 Million | - |
| Other Investing Activities | 52.79 Thousand | 39 Thousand | -52.1 Thousand | -33.48 Thousand | - |
| Financing Cash Flow | 724.00 | 235.00 | 379.21 Thousand | 44.53 Million | 196 Thousand |
| Debt repayment | - | - | - | -400 Thousand | -200 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | 305 Thousand | 339 Thousand | 194 Thousand | - | - |
| Common Stock Issuance | 724 Thousand | 662 Thousand | 379.21 Million | 1000.00 | - |
| Other Financing Activities | 724.00 | 235.00 | 379.21 Thousand | 44.93 Million | 396 Thousand |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | -1.24 Million | 5.38 Million | 2.41 Million | -413 Thousand | - |
| Inventory | - | - | - | - | - |
| Other working capital | 1.97 Million | -3.39 Million | -1.01 Million | -398 Thousand | 1.81 Million |
| Cash at beginning of period | 26.5 Million | 298.56 Million | 2.37 Million | 77 Thousand | 20 Thousand |
| Cash at end of period | 21.2 Million | 26.5 Million | 298.56 Million | 2.37 Million | 77 Thousand |
| Capital Expenditure | -256 Thousand | -918 Thousand | -1.53 Million | -76 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -5.3 Million | -272.06 Million | 296.19 Million | 2.3 Million | 57 Thousand |
| Free Cash Flow | -58.81 Million | -52.23 Million | -30.91 Million | -8.74 Million | -139 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.79 Million | -11.1 Million | -11.84 Million | -66.86 Million | -15.78 Million | -19.93 Million |
| Depreciation & Amortization | 151 Thousand | 143 Thousand | 138 Thousand | 537 Thousand | 137 Thousand | 133 Thousand |
| Deferred income taxes | - | - | 3.1 Million | - | -1.7 Million | -1.39 Million |
| Stock-based compensation | 3.29 Million | 3.18 Million | 2.72 Million | 13.08 Million | 3.21 Million | 3.71 Million |
| Change in working capital | -1.34 Million | -2.93 Million | -1.98 Million | 728 Thousand | -400 Thousand | 3.66 Million |
| Other non-cash items | 2.75 Million | 4.26 Million | 3.97 Million | 9.35 Million | 8000.00 | 10 Thousand |
| Investing Cash Flow | 27.33 Million | 20.61 Million | 5.55 Million | 52.53 Million | 15.26 Million | 11.98 Million |
| Investments in PPE | -161 Thousand | -195 Thousand | -27 Thousand | -256 Thousand | -53 Thousand | -89 Thousand |
| Acquisitions | - | - | 31.89 Thousand | - | - | -12.07 Thousand |
| Investment purchases | -53.63 Million | -45.65 Million | -74.15 Million | -224.7 Million | -54.56 Million | -62.36 Million |
| Sales/Maturities of investments | 81.12 Million | 66.47 Million | 79.73 Million | 277.49 Million | 69.88 Million | 74.44 Million |
| Other Investing Activities | 27.49 Thousand | 20.81 Thousand | 5582.00 | 52.79 Thousand | 15.31 Thousand | 12.07 Thousand |
| Financing Cash Flow | 229 Thousand | 20 Thousand | 501.00 | 724.00 | 13.00 | 210.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 305 Thousand | 305 Thousand | - | - |
| Common Stock Issuance | 229 Thousand | 20 Thousand | 501 Thousand | 724 Thousand | 13 Thousand | 210 Thousand |
| Other Financing Activities | 229.00 | 20.00 | 501.00 | 724.00 | 13.00 | 210.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -720 Thousand | -2.52 Million | -2.81 Million | -1.24 Million | 239 Thousand | 3.07 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -628 Thousand | -411 Thousand | 823 Thousand | 1.97 Million | -639 Thousand | 598 Thousand |
| Cash at beginning of period | 29.39 Million | 21.2 Million | 27.94 Million | 26.5 Million | 27.19 Million | 28.8 Million |
| Cash at end of period | 45.69 Million | 29.39 Million | 21.2 Million | 21.2 Million | 27.94 Million | 27.19 Million |
| Capital Expenditure | -161 Thousand | -195 Thousand | -27 Thousand | -256 Thousand | -53 Thousand | -89 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 16.3 Million | 8.19 Million | -6.74 Million | -5.3 Million | 745 Thousand | -1.61 Million |
| Free Cash Flow | -11.42 Million | -12.63 Million | -12.82 Million | -58.81 Million | -14.58 Million | -13.89 Million |
GMS
3302
6393
NAHARCAP
7823
VVX